Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:38:12.759Z.
Calculation as of: 2026-10-06T19:38:12.759Z.
Quote observation: 2026-10-06T19:35:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2f5c47113f9c506e2e082fd2a1fe30760bd520268ada69101bb9e18573fa4dd9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$852.84M
Free Cash Flow Yield
N/A
TTM Avg
2.73%
3Y Avg
5.44%
5Y Avg
9.24%
Market Cap
$854.88M
Free Cash Flow Yield
9.29%
TTM Avg
10.90%
3Y Avg
9.26%
5Y Avg
7.66%
Market Cap
$840.18M
Free Cash Flow Yield
N/A
TTM Avg
1.33%
3Y Avg
1.33%
5Y Avg
1.33%
Market Cap
$838.84M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$869.18M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$872.01M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$831.65M
Free Cash Flow Yield
N/A
TTM Avg
10.05%
3Y Avg
10.05%
5Y Avg
10.05%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SI-BONE, Inc. (SIBN) | $853.28M | N/A | N/A | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $852.84M | N/A | 2.73% | 5.44% | 9.24% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $854.88M | 9.29% | 10.90% | 9.26% | 7.66% |
| Alumis Inc. (ALMS)vs › | $843.04M | N/A | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $840.18M | N/A | 1.33% | 1.33% | 1.33% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $838.84M | N/A | N/A | N/A | N/A |
| SL Science Holding Ltd (SLBT)vs › | $869.18M | N/A | N/A | N/A | N/A |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $872.01M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $831.65M | N/A | 10.05% | 10.05% | 10.05% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $881.69M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
